Topic Highlight
Copyright ©2014 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Stem Cells. Apr 26, 2014; 6(2): 144-152
Published online Apr 26, 2014. doi: 10.4252/wjsc.v6.i2.144
Adipose mesenchymal stem cells in the field of bone tissue engineering
Cecilia Romagnoli, Maria Luisa Brandi
Cecilia Romagnoli, Maria Luisa Brandi, Metabolic Bone Diseases Branch, Department of Surgery and Translational Medicine, University of Florence, Florence 50139, Italy
Author contributions: Romagnoli C conceived and designed the paper, reviewed the literature and wrote the paper; Brandi ML revised and approved the final version of the paper.
Supported by The Regione Toscana-POR CRO FSE 2007-2013 and I.F.B. STRODER s.r.l.
Correspondence to: Maria Luisa Brandi, MD, PhD, Metabolic Bone Diseases Branch, Department of Surgery and Translational Medicine, University of Florence, Largo Palagi 1, Florence 50139, Italy. marialuisa.brandi@unifi.it
Telephone: +39-55-7946304 Fax: +39-55-7946303
Received: November 19, 2013
Revised: December 19, 2013
Accepted: March 3, 2014
Published online: April 26, 2014
Processing time: 184 Days and 20 Hours
Abstract

Bone tissue engineering represents one of the most challenging emergent fields for scientists and clinicians. Current failures of autografts and allografts in many pathological conditions have prompted researchers to find new biomaterials able to promote bone repair or regeneration with specific characteristics of biocompatibility, biodegradability and osteoinductivity. Recent advancements for tissue regeneration in bone defects have occurred by following the diamond concept and combining the use of growth factors and mesenchymal stem cells (MSCs). In particular, a more abundant and easily accessible source of MSCs was recently discovered in adipose tissue. These adipose stem cells (ASCs) can be obtained in large quantities with little donor site morbidity or patient discomfort, in contrast to the invasive and painful isolation of bone marrow MSCs. The osteogenic potential of ASCs on scaffolds has been examined in cell cultures and animal models, with only a few cases reporting the use of ASCs for successful reconstruction or accelerated healing of defects of the skull and jaw in patients. Although these reports extend our limited knowledge concerning the use of ASCs for osseous tissue repair and regeneration, the lack of standardization in applied techniques makes the comparison between studies difficult. Additional clinical trials are needed to assess ASC therapy and address potential ethical and safety concerns, which must be resolved to permit application in regenerative medicine.

Keywords: Adipose-derived stem cells; Bone tissue engineering; Osteogenic differentiation; Scaffold; Regenerative medicine

Core tip: The complex and dynamic process of bone tissue engineering is a challenging field in regenerative medicine. Current research is focused on the optimization and facilitation of bone regeneration by combining growth factors and mesenchymal stem cells with the many types of materials that have been studied as scaffolds. This review presents an overview of ideal scaffold properties and discusses the application of adipose-derived stem cells in bone tissue engineering and translational medicine.